Barbara Kay-Farrow is the Vice President of Quality Assurance and Compliance. She has over 30 years of experience in the Research, Pharmaceutical and CRO industries. Within the Quality Assurance field, Ms. Kay-Farrow has held a variety of roles of increasing responsibility includingpositions in auditing, computer system validation, controlled document management, contract auditor management, QA liaison, and management of QA staff. Most recently, before coming to Pharm-Olam, she headed a global team managing regulatory inspections and client audits.
As a member of the Research Quality Association’s (RQA) Computing Committee, she co-authored the booklet “Electronic Standard Operating Procedures,” published in 2014. Ms. Kay-Farrow also presents on the subject of Data Integrity.
Prior to joining Pharm-Olam, Ms. Kay-Farrow was with Covance for 12 years where she was a Global Senior Director of QA and Compliance. Before that, she held positions at Shire Pharmaceuticals, Quintiles, Glaxo Group Research, and Chiltern International Ltd.
Ms. Kay-Farrow holds a post-graduate diploma in Clinical Science from the University of Wales as well as undergraduate degrees in Microbiology, Immunology, and Pharmacology from the Institute of Biology in London. She served on RQA’s Computing Committee for 8 years.
